S3I Holdings, Inc. Releases Full-Featured Alpha Version of Immunity 2.0 Multi-Regulation Compliance Software Solution


CARLSBAD, Calif., June 14, 2004 (PRIMEZONE) -- S3I Holdings, Inc. (OTCBB:SEIH) today announced that its subsidiary, Securesoft Systems, Inc., has released a full-featured Alpha version of Immunity 2.0, its flagship compliance software product. Immunity 2.0 offers both increased security and productivity over the previous version of the trademarked Immunity product, which is currently in use in a number of hospitals, clinics and other medical facilities. Once fully-developed, Securesoft Systems (SSI) plans to integrate the new version of Immunity into its existing sales and marketing program targeting healthcare facilities and countless other entities across the United States that are subject to government compliance mandates.

Built from the ground up using the Microsoft .NET architecture, Immunity 2.0 offers a number of groundbreaking technologies in compliance management, including (1) a fully adaptable compliancy engine, allowing both internal and governmental mandates to be loaded into the system (2) a patent pending methodology for reviewing and assessing compliancy issues (3) a redesigned, customizable interface, including corporate branding as well as "quick change" look and feel to increase the users' experience and alleviate the complications of learning new software (4) a full suite of remediation tools, helping customers determine the best option based on varying risk factors, returns on investment and adaptability within their current company architecture (5) incorporation of the .NET security model to ensure safe transactions and access, and (6) integration of MS Office, XML and SOAP technologies.

Wayne Yamamoto, CEO of S3I Holdings Inc., commented, "The release of the Alpha version of Securesoft System's proprietary software is designed to allow SSI to handle regulations in addition to Health Insurance Portability and Accountability Act (HIPAA). Immunity 2.0 not only includes enhancements to reporting and simplifying the process flow for HIPAA, but is designed to allow customers to manage compliance with other mandates, such as the Occupational Safety Hazard Association (OSHA), the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), the Gramm-Leach-Bliley Act and the Sarbanes-Oxley Act, among others. This technology solution provides its clients with the ability to assess and monitor security and privacy policies, procedures and operations in order to manage compliance.

"We anticipate that sales of the new version of our trademarked Immunity software platform will be achieved in the very near future and that this product will enhance Securesoft System's reach into the growing healthcare market. The Company is extremely pleased to have moved forward in this direction, and looks forward to building additional shareholder value in part through the growth of sales for Securesoft Systems," added Mr. Yamamoto.

Company Profile

S3I Holdings, Inc. (http://www.s3i.us) is a Business Development Company regulated by the Investment Company Act of 1940. Its first operating subsidiary, Securesoft Systems, Inc. (http://www.securesoftsystems.com), was acquired in April 2003 and is a leader in compliance and risk management software, services and Internet technologies for regulated industries. S3I Holdings is currently seeking to acquire additional synergistic companies and is focused on assembling a portfolio of investments that will provide value to its shareholders.

This release contains forward-looking statements which involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements are based on currently available information which management has assessed but which is dynamic and subject to rapid change due to risks and uncertainties that affect our business, including, but not limited to, the impact of competitive products and pricing, limited visibility into future product demand, regulatory interpretation, and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission.



            

Mot-clé


Coordonnées